iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
Authors
Keywords
-
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-07
DOI
10.1186/s12951-019-0553-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Competition of charge-mediated and specific binding by peptide-tagged cationic liposome–DNA nanoparticles in vitro and in vivo
- (2018) Emily Wonder et al. BIOMATERIALS
- Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles
- (2018) Samrat Mazumdar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells
- (2018) Rocío G. Sampayo et al. JOURNAL OF CELL BIOLOGY
- Estrogen Receptor‐Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance
- (2018) Adam M. Brufsky et al. ONCOLOGIST
- Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice
- (2018) Lorena Simón-Gracia et al. Oncotarget
- Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth
- (2017) Shweta Sharma et al. NANO LETTERS
- Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
- (2017) Pablo Scodeller et al. Scientific Reports
- iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes
- (2016) Lorena Simón-Gracia et al. BIOMATERIALS
- The complexity of integrins in cancer and new scopes for therapeutic targeting
- (2016) Hellyeh Hamidi et al. BRITISH JOURNAL OF CANCER
- Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo
- (2016) NR Ravikumara et al. JOURNAL OF BIOMATERIALS APPLICATIONS
- Organoids: A historical perspective of thinking in three dimensions
- (2016) Marina Simian et al. JOURNAL OF CELL BIOLOGY
- Antiestrogens: structure activity relationships and use in breast cancer treatment
- (2016) Tatiana Traboulsi et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study
- (2016) Ankit Dhaundiyal et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy
- (2016) L. Simon-Gracia et al. MOLECULAR CANCER THERAPEUTICS
- Molecular engineering of polymersome surface topology
- (2016) L. Ruiz-Perez et al. Science Advances
- Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
- (2015) Sijumon Kunjachan et al. CHEMICAL REVIEWS
- Engineering Functional Polymer Capsules toward Smart Nanoreactors
- (2015) Jens Gaitzsch et al. CHEMICAL REVIEWS
- Selective estrogen receptor modulators in clinical practice: a safety overview
- (2015) Amanda J Ellis et al. Expert Opinion On Drug Safety
- iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells
- (2015) Xiaoli Mao et al. Nanomedicine
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage
- (2015) Chi-Hsuan Chang et al. Stem Cell Reports
- Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer
- (2014) V Craig Jordan ENDOCRINE-RELATED CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-Penetrating iRGD Peptide Inhibits Metastasis
- (2014) K. N. Sugahara et al. MOLECULAR CANCER THERAPEUTICS
- Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate
- (2013) Diego Raffo et al. BREAST CANCER RESEARCH AND TREATMENT
- Enhanced drug delivery to melanoma cells using PMPC-PDPA polymersomes
- (2013) Carla Pegoraro et al. CANCER LETTERS
- Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer
- (2013) Young Kyung Bae et al. HUMAN PATHOLOGY
- Targeting Tamoxifen to Breast Cancer Xenograft Tumours: Preclinical Efficacy of Folate-Attached Nanoparticles Based on Alginate-Cysteine/Disulphide-Bond-Reduced Albumin
- (2013) A. Martínez et al. PHARMACEUTICAL RESEARCH
- Neuropilins: expression and roles in the epithelium
- (2012) Jonathan R. L. Wild et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Elevated Levels of Lewis Y and Integrin α5β1 Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma
- (2012) Zhenhua Hu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enhanced preclinical efficacy of tamoxifen developed as alginate–cysteine/disulfide bond reduced albumin nanoparticles
- (2012) A. Martínez et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy
- (2012) Iris Eke et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Controlling Polymersome Surface Topology at the Nanoscale by Membrane Confined Polymer/Polymer Phase Separation
- (2011) Caterina LoPresti et al. ACS Nano
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen
- (2011) Bruno M Simões et al. Future Oncology
- Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
- (2011) Ada Ao et al. PLoS One
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Effects of estrogen on the proportion of stem cells in the breast
- (2010) Bruno M. Simões et al. BREAST CANCER RESEARCH AND TREATMENT
- Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer
- (2010) Chang Gong et al. PLoS One
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- Integrins in mammary-stem-cell biology and breast-cancer progression - a role in cancer stem cells?
- (2009) S. M. Pontier et al. JOURNAL OF CELL SCIENCE
- A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice
- (2008) Marina Simian et al. BREAST CANCER RESEARCH AND TREATMENT
- 1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
- (2008) C. C. Park et al. CANCER RESEARCH
- Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response
- (2008) J. Helleman et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search